2023 annual financial data
ORIC Pharmaceuticals 2023 Operating margin
ORIC Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -110,780,000 USD and net income was -100,697,000 USD.
Operating cash flow was -85,688,000 USD.
Get free ORIC Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -110,780,000 USD
- Net income
- -100,697,000 USD
- Operating cash flow
- -85,688,000 USD